Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

  • There is currently no data for AGL

Angle News

Angle hails successful completion of Eisai contract; approval by Astra
21 Mar 2025

Angle hails successful completion of Eisai contract; approval by Astra

(Alliance News) - Angle PLC on Friday said the results of an Eisai Co Ltd pilot study supported the capability of the Parsortix system for real-time a...

Angle completes assay development projects
21 Mar 2025

Angle completes assay development projects

(Sharecast News) - Angle announced on Friday the successful completion of assay development projects for AstraZeneca and Eisai, further expanding its ...

Angle reports breakthrough in dual cancer DNA analysis
29 Jan 2025

Angle reports breakthrough in dual cancer DNA analysis

(Alliance News) - Angle PLC on Wednesday released successful results from its new dual circulating tumour DNA and circulating tumour cell DNA workflow...

Angle's Parsortix system used in 'breakthrough' breast cancer research
24 Jan 2025

Angle's Parsortix system used in 'breakthrough' breast cancer research

(Sharecast News) - Liquid biopsy specialist Angle announced on Friday that its Parsortix system played a pivotal role in groundbreaking breast cancer ...

Angle fails to win market confidence despite narrowing loss in 2024
23 Jan 2025

Angle fails to win market confidence despite narrowing loss in 2024

(Alliance News) - Angle PLC on Thursday said it expected losses to have narrowed in 2024, but its share price suggested lingering market wariness.

Berenberg slashes target price on Angle
23 Jan 2025

Berenberg slashes target price on Angle

(Sharecast News) - Analysts at Berenberg slashed their target price on liquid biopsy specialist Angle from 70.0p to 40.0p on Thursday but said the gro...

LONDON BROKER RATINGS: HSBC raises FirstGroup, Goldman cuts Ithaca
23 Jan 2025

LONDON BROKER RATINGS: HSBC raises FirstGroup, Goldman cuts Ithaca

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: